Sage Therapeutics
SAGE
#7422
Rank
A$0.47 B
Marketcap
$7.76
Share price
3.92%
Change (1 day)
-73.69%
Change (1 year)

Sage Therapeutics (SAGE) - Cash on Hand

Cash on Hand as of September 2024 : A$0.87 Billion

According to Sage Therapeutics 's latest financial reports the company has A$0.87 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Sage Therapeutics - Cash on Hand chart (from 2013 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$1.10 B-40.88%
2022-12-31A$1.86 B-22.19%
2021-12-31A$2.40 B-11.99%
2020-12-31A$2.73 B89.58%
2019-12-31A$1.44 B9.95%
2018-12-31A$1.30 B97.1%
2017-12-31A$0.66 B20.52%
2016-12-31A$0.55 B115.1%
2015-12-31A$0.25 B64.21%
2014-12-31A$0.15 B1626.43%
2013-12-31A$9.04 M235.38%
2012-12-31A$2.69 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$0.14 B-83.40%๐Ÿ‡บ๐Ÿ‡ธ USA
A$23.62 M-97.30%๐Ÿ‡บ๐Ÿ‡ธ USA
A$3.79 B 333.03%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
A$0.49 B-43.30%๐Ÿ‡บ๐Ÿ‡ธ USA